© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
Breast Cancer Screening: Start Young and Stay With It
October 18, 2024
Women who receive a false positive breast cancer screening result may forego future mammograms. Thoughtfully counsel any young patient who may be feeling this way.
Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause
October 17, 2024
Bayer announced 12 presentations focused on symptoms of menopause and effects of its investigational oral nonhormonal medication elinzanetant.
Effective Breast Cancer Prevention Requires A Primary Care Advocate, Expert Says
October 17, 2024
After a false positive breast cancer screening result, women may be reluctant to participate in future screening, a topic that could benefit from the primary care touch.
False Positive Breast Cancer Screening Linked with Greater Risk of Later Diagnosis
October 16, 2024
Even after adjusting for breast density, studies reveal a significantly greater risk for a cancer diagnosis within 2 decades. A UC Davis expert offers details.
Family Caregiving for Alzheimer Disease Worth a 6-Figure Annual Salary: New Research
October 16, 2024
Supported by Otsuka, new research calculated the value of daily hours spent on basic chores and complex tasks required to support a loved one with AD.
FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List
October 15, 2024
Update: The FDA has told compounding pharmacies they may resume production of tirzepatide products while the agency further investigates supply.
How Likely is a False Positive Breast Cancer Screening Result? Veteran Researcher Explains
October 15, 2024
A false positive finding on a screening mammogram is fairly common, according to UC Davis biostatistician Diana Miglioretti, PhD. Here's why.
Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial
October 15, 2024
Use of the unique STS101 drug device combination proved safe, well tolerated, and effective with as needed use over 12 months, reported Satsuma Pharmaceuticals.
After a False Positive Result, Screening Mammography May Not be a Priority for Some Women
October 14, 2024
The group of women least likely to return for a regular preventive screening mammogram after a false positive result surprised this primary investigator.
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
October 14, 2024
Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.